Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.

[1]  Judy E. Kim,et al.  Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9. , 2010, Archives of ophthalmology.

[2]  Matthew D. Davis,et al.  Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. , 2010, Ophthalmology.

[3]  I. Scott,et al.  The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4. , 2009, Archives of ophthalmology.

[4]  Ingrid U Scott,et al.  SCORE Study report 3: study design and baseline characteristics. , 2009, Ophthalmology (Rochester, Minn.).

[5]  Ingrid U Scott,et al.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.

[6]  I. Scott,et al.  SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. , 2009, Ophthalmology.

[7]  Chris A Johnson,et al.  A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. , 2003, American journal of ophthalmology.

[8]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[9]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[10]  S. Hayreh.  Central Retinal Vein Occlusion , 2010 .

[11]  E. Chew,et al.  Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. , 1998, Ophthalmology.

[12]  David J. Wilson,et al.  Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. , 1995, Ophthalmology.

[13]  D. Shin,et al.  Risk factors for retinal vein occlusions. A case-control study. , 1992, Ophthalmology.

[14]  M. Elman,et al.  The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. , 1990, Ophthalmology.

[15]  Appiah Ap,et al.  Risk factors associated with branch vs. central retinal vein occlusion. , 1989 .

[16]  Greenidge Kc,et al.  Factors associated with retinal-vein occlusion in Hispanics. , 1987 .

[17]  D. Finkelstein,et al.  Argon laser photocoagulation for macular edema in branch vein occlusion. , 1986, Ophthalmology.

[18]  D. Finkelstein,et al.  Risk factors of branch retinal vein occlusion. , 1986, Archives of ophthalmology.

[19]  A. Patz.  Argon laser photocoagulation for macular edema in branch vein occlusion. , 1984, American journal of ophthalmology.

[20]  A. Hunyor,et al.  Systemic factors contributory to retinal vein occlusion. , 1978, Archives of internal medicine.

[21]  C. Walker.  Ophthalmology , 1859, Bristol medico-chirurgical journal.

[22]  L. Aiello.  A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. , 2008, Ophthalmology.

[23]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[24]  C. Trempe,et al.  Risk factors associated with branch vs. central retinal vein occlusion. , 1989, Annals of ophthalmology.

[25]  K. Greenidge,et al.  Factors associated with retinal-vein occlusion in Hispanics. , 1987, Annals of ophthalmology.

[26]  F. James Rohlf,et al.  Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .